GlassScriptPhysician profile
Stacy H Graham
NPI 1912093501
$8,280.82
in general payments reported to CMS, 2019-2025
35 companies · $1,051 in 2025
The $1,051 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,338 · 2020: $84.86 · 2021: $338 · 2022: $981 · 2023: $1,817 · 2024: $1,672 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,539.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,427.37 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,283.06 | 2019-2025 | |
| Amgen INC. | $898.46 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $659.84 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $413.66 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $405.12 | 2019-2025 | Watchman Access System, General - Vascular Intervention, Bodyguardian |
| Merck Sharp & Dohme LLC | $395.45 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $384.76 | 2022-2025 | Farxiga, Brilinta, Wainua |
| Janssen Pharmaceuticals, INC | $354.13 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $345.21 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $240.83 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $170.58 | 2023-2024 | Linq II, Attain Command + Surevalve |
| Atricure, INC. | $165.41 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Abbott Laboratories | $156.49 | 2022-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Talisman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.04 | 2023-2024 | Lifevest |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $136.99 | 2019 | |
| Alnylam Pharmaceuticals INC. | $106.52 | 2022-2024 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $67.50 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $63.46 | 2022-2023 | Nexletol |
| Cvrx, INC. | $61.13 | 2022-2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $56.94 | 2022-2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $48.72 | 2024-2025 | Uptravi, Opsynvi, Opsumit |
| Lexicon Pharmaceuticals, INC. | $44.97 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $44.52 | 2024 | |
| Corcept Therapeutics | $38.75 | 2025 | Korlym |
| Philips North America LLC | $25.75 | 2025 | Event |
| Amryt Pharma Holdings LTD | $24.26 | 2023 | Juxtapid |
| Cardiva Medical, INC. | $19.20 | 2019 | |
| Altathera Pharmaceuticals LLC | $17.45 | 2025 | Sotalol Hydrochloride |
| Terumo Medical Corporation | $16.49 | 2024 | Tr Band, Metacross Otw |
| Lundbeck LLC | $14.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.39 | 2025 | |
| Cashflow Solutions, LLC | $14.16 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.23 | 2019 | |
| Amarin Pharma, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.